This bill amends section 766.101 of the Florida Statutes, which pertains to medical review committees and their immunity from liability. The definition of a "medical review committee" is expanded to include additional entities, such as a managing entity as defined in s. 394.9082(2), and clarifies that these committees may include employees, agents, or consultants deemed necessary for peer review, utilization review, or mortality review of treatment services. The bill also revises the language regarding the quality assurance programs of mental health treatment facilities and substance abuse treatment programs, removing the requirement for guidelines to be approved by the governing board.

Furthermore, the bill updates provisions related to the discovery and evidence in civil and administrative actions, ensuring that the investigations, proceedings, and records of these committees remain protected from being introduced as evidence in legal actions against health service providers or managing entities. It specifies that individuals attending committee meetings cannot be compelled to testify about the proceedings, while still allowing for the use of information from original sources. The act is set to take effect on July 1, 2026.